Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
ABSI 
Absci Corp (ABSI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: ABSI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $8.11
1 Year Target Price $8.11
| 5 | Strong Buy |
| 4 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -22.8% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 547.35M USD | Price to earnings Ratio - | 1Y Target Price 8.11 |
Price to earnings Ratio - | 1Y Target Price 8.11 | ||
Volume (30-day avg) 9 | Beta 2.14 | 52 Weeks Range 2.01 - 6.33 | Updated Date 12/14/2025 |
52 Weeks Range 2.01 - 6.33 | Updated Date 12/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.91 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -7977.25% |
Management Effectiveness
Return on Assets (TTM) -30.62% | Return on Equity (TTM) -55.68% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 401097372 | Price to Sales(TTM) 194.44 |
Enterprise Value 401097372 | Price to Sales(TTM) 194.44 | ||
Enterprise Value to Revenue 142.49 | Enterprise Value to EBITDA -0.39 | Shares Outstanding 150371531 | Shares Floating 132725432 |
Shares Outstanding 150371531 | Shares Floating 132725432 | ||
Percent Insiders 9.28 | Percent Institutions 66.06 |
About Absci Corp
Exchange NASDAQ | Headquaters Vancouver, WA, United States | ||
IPO Launch date 2021-07-22 | Founder, CEO, President & Director Mr. Sean McClain | ||
Sector Healthcare | Industry Biotechnology | Full time employees 156 | Website https://www.absci.com |
Full time employees 156 | Website https://www.absci.com | ||
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.